Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine

CUI Yuanyuan; ZHOU Yongfeng; MA Yanqin; ZHANG Rongrong; DONG Yi; FANG Jixiang; WANG Guoqiang; ZHANG Ping

doi:10.14009/j.issn.1672-2124.2020.06.001

您当前的位置：

首页 >

文章列表页 >

Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine

更新时间：2022-10-08

- Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine
- Vol. 20, Issue 6, Pages: 641-644(2020)
- 作者机构：
  
  中国人民解放军总医院第五医学中心中药房
- 作者简介：
- 基金信息：
- DOI：10.14009/j.issn.1672-2124.2020.06.001
  CLC： R259
- Published：2020，
扫描看全文
[1]崔园园,周永峰,马艳芹,张蓉蓉,董旖,房吉祥,王国强,张萍.基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用[J].中国医院用药评价与分析,2020,20(06):641-644.

CUI Yuanyuan, ZHOU Yongfeng, MA Yanqin, et al. Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine. [J]. 20(6):641-644(2020)
[1]崔园园,周永峰,马艳芹,张蓉蓉,董旖,房吉祥,王国强,张萍.基于中医“毒邪”理论探析治疗新型冠状病毒肺炎中药的临床应用[J].中国医院用药评价与分析,2020,20(06):641-644. DOI： 10.14009/j.issn.1672-2124.2020.06.001.

CUI Yuanyuan, ZHOU Yongfeng, MA Yanqin, et al. Clinical Application of Traditional Chinese Medicine in the Treatment of COVID-19 Based on the Poison Theory of Traditional Chinese Medicine. [J]. 20(6):641-644(2020) DOI： 10.14009/j.issn.1672-2124.2020.06.001.

摘要

作为一种急性病毒性传染病

新型冠状病毒肺炎（COVID-19）已被纳入《中华人民共和国传染病防治法》规定的乙类传染病。抗病毒药是治疗病毒性传染病的重要手段

针对COVID-19

目前已有148项相关药物注册临床试验

但至今尚无特效药。鉴于近年来从中医"毒邪"理论辨治难治性、病毒性疾病的效果凸显且应用广泛

本文试从中医"毒邪"理论探讨COVID-19的发病机制

整合分析现有的治疗COVID-19中药的筛选和临床应用规律

以期发现具有潜在价值的基础方药

为治疗COVID-19中药的临床应用提供参考。

Abstract

As a kind of acute viral infectious disease

COVID-19 has been included in the category B infectious diseases under the Law of the People’s Republic of China on the Prevention and Control of Infectious Diseases. The antiviral drugs are an important tool in the treatment of viral infectious diseases. For COVID-19

148 kinds of elated drugs have been registered in clinical trials

but there is no effective drug yet. In view of the significant and widespread application of Poison Theory of traditional Chinese medicine in the treatment of refractory and viral diseases in recent years

this paper attempts to explore the pathogenesis of COVID-19 from Poison Theory of traditional Chinese medicine

and integrates and analyzes the existing screening and clinical application patterns of traditional Chinese medicine for the treatment of COVID-19

with a view to discovering potentially valuable basic prescription drugs for the clinical application of traditional Chinese medicine

and provide reference for the treatment of COVID-19.

关键词

新型冠状病毒肺炎中医药“毒邪”理论

Keywords

COVID-19Traditional Chinese medicinePoison Theory

references

查看原文

Views

176

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Medication Rules of Traditional Chinese Medicine in the Treatment of Liver Cancer After Transcatheter Arterial Chemoembolization Based on Data Mining

Regularity and Mechanism of Traditional Chinese Medicine in the Treatment of Osteoporosis Based on Data Mining and Network Pharmacology

Progress of Antiviral Research of Arbidol

Clinical Efficacy and Safety of Qi-Tonifying and Blood-Invigorating Method Combined with Western Medicine Conventional Therapy in the Treatment of Qi-Deficiency and Blood-Stasis Type of Acute Ischemic Stroke

Related Author

ZHANG Yanjie

SUN Fengxia

LI Xiaoling

ZHANG Yingxue

XU Chunjun

DUAN Xiaoyun

ZHONG Ruixue

WU Chuanhong

Related Institution

Dept.of Hepatology, Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

Dept.of Pharmacy, Sichuan Province Orthopedic Hospital

Dept.of Pharmacy, People’ s Hospital of Dazu District

Dept.of Dermatology, Jiangbei Hospital of Traditional Chinese Medicine

Dept.of Emergency, Renmin Hospital of Wuhan University

⁰